PWMG
MLYS icon

Private Wealth Management Group’s Mineralys Therapeutics MLYS Stock Holding History

Private Wealth Management Group’s Portfolio MLYS Stock Details MLYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$756 Hold
28
– – ﹤0.01% 1349
2026
Q1 		$759 Hold
28
– – ﹤0.01% 1297
2025
Q4 		$1.02K Sell
28
-22
-44% -$882 ﹤0.01% 1265
2025
Q3 		$1.9K Hold
50
– – ﹤0.01% 1123
2025
Q2 		$677 Hold
50
– – ﹤0.01% 1360
2025
Q1 		$794 Hold
50
– – ﹤0.01% 1321
2024
Q4 		$616 Hold
50
– – ﹤0.01% 1405
2024
Q3 		$606 Hold
50
– – ﹤0.01% 1395
2024
Q2 		$585 Hold
50
– – ﹤0.01% 1404
2024
Q1 		$646 Hold
50
– – ﹤0.01% 1387
2023
Q4 		$430 Buy
+50
New +$393 ﹤0.01% 1483

Other funds holding MLYS

CP
Catalys Pacific Tokyo, Japan $229M AUM 100.3% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Private Wealth Management Group's MLYS Position: Q2 2026 in Review

Private Wealth Management Group held its Mineralys Therapeutics (MLYS) position steady in Q2 2026 at 28 shares worth $756. The position accounts for ﹤0.01% of the portfolio, ranked #1349.

Private Wealth Management Group first reported a position in MLYS in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.9K in Q3 2025. 224 funds tracked by Wall St. Rank hold MLYS as of Q2 2026.

  • Private Wealth Management Group held 28 shares of Mineralys Therapeutics worth $756 as of Q2 2026.
  • Private Wealth Management Group left its Mineralys Therapeutics share count unchanged in Q2 2026.
  • Mineralys Therapeutics made up ﹤0.01% of Private Wealth Management Group's portfolio in Q2 2026, its #1349 holding.
  • Private Wealth Management Group first reported a position in Mineralys Therapeutics in Q4 2023 and has held it in 11 quarters since.
  • Private Wealth Management Group's Mineralys Therapeutics position peaked at $1.9K in Q3 2025.
  • 224 funds tracked by Wall St. Rank held Mineralys Therapeutics as of Q2 2026.

Based on Private Wealth Management Group's 13F filing for Q2 2026, filed 27 Jul 2026.